Distinguishing Ontario ginseng landraces and ginseng species using NMR-based metabolomics.

The use of (1)H-NMR-based metabolomics to distinguish and identify unique markers of five Ontario ginseng (Panax quinquefolius L.) landraces and two ginseng species (P. quinquefolius and P. ginseng) was evaluated. Three landraces (2, 3, and 5) were distinguished from one another in the principal component analysis (PCA) scores plot. Further analysis was conducted and specific discriminating metabolites from the PCA loadings were determined. Landraces 3 and 5 were distinguishable on the basis of a decreased NMR intensity in the methyl ginsenoside region, indicating decreased overall ginsenoside levels. In addition, landrace 5 was separated by an increased amount of sucrose relative to the rest of the landraces. Landrace 2 was separated from the rest of the landraces by the increased level of ginsenoside R(b1). The Ontario P. quinquefolius was also compared with Asian P. ginseng by PCA, and clear separation between the two groups was detected in the PCA scores plot. The PCA loadings plot and a t-test NMR difference plot were able to identify an increased level of maltose and a decreased level of sucrose in the Asian ginseng compared with the Ontario ginseng. An overall decrease of ginsenoside content, especially ginsenoside R(b1), was also detected in the Asian ginseng's metabolic profile. This study demonstrates the potential of NMR-based metabolomics as a powerful high-throughput technique in distinguishing various closely related ginseng landraces and its ability to identify metabolic differences from Ontario and Asian ginseng. The results from this study will allow better understanding for quality assessment, species authentication, and the potential for developing a fully automated method for quality control.

Inhibition of advanced glycation end product formation by medicinal plant extracts correlates with phenolic metabolites and antioxidant activity.

Nonenzymatic formation of advanced glycation end products (AGEs) is accelerated under hyperglycemic conditions characteristic of type 2 diabetes mellitus and contributes to the development of vascular complications. As such, inhibition of AGE formation represents a potential therapeutic target for the prevention and treatment of diabetic complications. In the present study, ethanolic extracts of 17 medicinal plants were assessed for inhibitory effects on in vitro AGE formation through fluorometric and immunochemical detection of fluorescent AGEs and N(ε)-(carboxymethyl)lysine adducts of albumin (CML-BSA), respectively. Most extracts inhibited fluorescent AGE formation with IC (50) values ranging from 0.4 to 38.6 µg/mL and all extracts reduced CML-BSA formation but to differing degrees. Results obtained through both methods were highly correlated. Antiglycation activities were positively correlated with total phenolic content, free radical scavenging activity and reduction in malonyldiadehyde levels following oxidation of low-density lipoprotein, but negatively correlated with lag time to formation of conjugated dienes. Together, these results provide evidence that antioxidant phenolic metabolites mediate the antiglycation activity of our medicinal plant collection, a relationship that likely extends to other medicinal and food plants.

Seasonal phytochemical variation of anti-glycation principles in lowbush blueberry (Vaccinium angustifolium).

Diabetic hyperglycaemia promotes the production of advanced glycation end-products (AGEs), which play a significant role in the development of complications associated with type 2 diabetes mellitus. Vaccinium angustifolium, a medicinal plant used for the treatment of diabetes, produces a variety of phenolic metabolites with putative anti-diabetic activities. To assess optimal cultivation time, seasonal changes in the concentration of six phenolic compounds in leaves and twelve compounds in stems were examined using HPLC-DAD and examined in relation to seasonal changes in AGE inhibition activity, assessed with a fluorescence-based assay. A seasonal decline occurred in the concentration of chlorogenic acid, rutin, and quercetin 3-arabinoside in leaves and chlorogenic acid in stems. The concentration of (+)-catechin, and (-)-epicatechin in stems declined within two weeks before rising and fluctuating insignificantly. AGE inhibition activity of leaves was significantly greater at the final compared to the initial collection date whereas the activity of stems did not change significantly. Relative to the leaf extract, the stem was a more potent inhibitor of AGE formation, which could be a result of the unique phytochemistry of stems. Together, these results revealed significant seasonal variation in the phenolic profile and anti-glycation effects of V. angustifolium extracts and indicated late summer as the collection time yielding optimal activity.